Renal dopaminergic defect in C57Bl/6J mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 297, Issue 6, 2009, Pages

  Escano, Crisanto S ^a   Armando, Ines ^a   Wang, Xiaoyan ^a   Asico, Laureano D ^a   Pascua, Annabelle ^a   Yang, Yu ^a   Wang, Zheng ^a   Lau, Yuen Sum ^b   Jose, Pedro A ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

Angiotensin II receptors; Dopamine receptors; GRK4; Reactive oxygen species

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 ISOPROSTANE; ALBUMIN; ANGIOTENSIN 1 RECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 5 RECEPTOR; FENOLDOPAM; G PROTEIN COUPLED RECEPTOR KINASE 4; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; C57BL 6 MOUSE; CONTROLLED STUDY; DIET; HIGH SODIUM INTAKE; KIDNEY DYSFUNCTION; MALE; MICROALBUMINURIA; MOUSE; MOUSE STRAIN; NATRIURESIS; NONHUMAN; PARATHYROID GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENAL DOPAMINERGIC DEFECT; SODIUM EXCRETION; SWISS JAMES LAMBERT MOUSE; TELEMETRY;

ALBUMINURIA; ANIMALS; BENZAZEPINES; BLOOD PRESSURE; DINOPROST; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FENOLDOPAM; GENOTYPE; KIDNEY; MALE; MICE; MICE, INBRED C57BL; NATRIURESIS; OXIDATIVE STRESS; PARATHYROID HORMONE; PHENOTYPE; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; SODIUM CHLORIDE, DIETARY; SPECIES SPECIFICITY;

EID: 72449180358     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00147.2009     Document Type: Article

References (51)

1. Armando I, Carranza A, Nishimura Y, Hoe KL, Barontini M, Terrón JA, Falcón-Neri A, Ito T, Juorio AV, Saavedra JM. Peripheral administration of an angiotensin II AT1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology 142: 3880-3889, 2001. (Pubitemid 32802660)
2. Armando I, Nowicki S, Aguirre J, Barontini M. A decreased tubular uptake of DOPA results in defective renal dopamine production in aged rats. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1087-F1092, 1995.
3. Armando I, Wang X, Villar VA, Jones JE, Asico LD, Escano C, Jose PA. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension 49: 672-678, 2007. (Pubitemid 46263212)
4. 4Cl solutions by 28 mouse strains. Behav Genet 32: 445-457, 2002.
5. Bayorh MA, Ganafa AA, Socci RR, Silvestrov N, Abukhalaf IK. The role of oxidative stress in salt-induced hypertension. Am J Hypertens 17: 31-36, 2004. (Pubitemid 38064756)
6. Banday AA, Lau YS, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 51: 367-375, 2008.
7. Carey RM. Theodore Cooper Lecture: Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 38: 297-302, 2001.
8. Carlson S, Wyss M. Long term telemetric recording of arterial pressure and heart rate in mice fed basal and high NaCl diets. Hypertension 35: e1-e5, 2000.
9. Carlström M, Sällström J, Skøtt O, Larsson E, Wählin N, Persson AEG. Hydronephrosis causes salt-sensitive hypertension and impaired renal concentrating ability in mice. Acta Physiol (Oxf) 189: 293-301, 2007. (Pubitemid 46256099)
10. Crowley SD, Frey CW, Gould SK, Griffiths R, Ruiz P, Burchette JL, Howell DN, Makhanova N, Yan M, Kim HS, Tharaux PL, Coffman TM. Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol 295: F515-F524, 2008.
11. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 15: 560-569, 1990. (Pubitemid 20187600)
12. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 99: 3872-3877, 2002. (Pubitemid 34252198)
13. Gill JR Jr, Grossman E, Goldstein DS. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension. Hypertension 18: 614-621, 1991.
14. Grossman A, Hoffman A, Tamrat M, Armando I, Keiser HR, Goldstein DS. Endogenous DOPA and dopamine responses to dietary salt loading in salt-sensitive rats. J Hypertens 9: 259-263, 1991.
15. Hartner A, Cordasic N, Klanke B, Veelken R, Hilgers KF. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice. Nephrol Dial Transplant 18: 1999-2004, 2003.
16. Helkamaa T, Männistö PT, Rauhala P, Cheng ZJ, Finckenberg P, Huotari M, Gogos JA, Karayiorgou M, Mervaala EM. Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice. J Hypertens 21: 2365-2374, 2003. (Pubitemid 38293577)
17. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228: 134-142, 2003.
18. Iguchi M, Kakinuma Y, Kurabayashi A, Sato T, Shuin T, Hong SB, Schmidt LS, Furihata M. Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney. Nephron Exp Nephrol 110: e82-e90, 2008.
19. Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 11: 87-92, 2002. (Pubitemid 34053343)
20. Kren S, Hostetter TH. The course of the remnant kidney model in mice. Kidney Int 56: 333-337, 1999. (Pubitemid 29300552)
21. Kirchhoff F, Krebs C, Abdulhag UN, Meyer-Schwesinger C, Maas R, Helmchen U, Hilgers KF. Rapid development of severe end-organ damage in C57Bl/6JBl/6 mice by combining DOCA salt and angiotensin II. Kidney Int 73: 643-650, 2008. (Pubitemid 351265325)
22. Korshunov VA, Berk BC. Strain-dependent vascular remodeling: the "Glagov phenomenon" is genetically determined. Circulation 110: 220-226, 2004.
23. Lau YS, Roels C, Novikova L. MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact. Neurosci Res 52: 371-378, 2005. (Pubitemid 40917216)
24. Leonard AM, Chafe LL, Montani JP, Van Vliet BN. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice. Am J Hypertens 19: 1264-1269, 2006. (Pubitemid 44856255)
25. Mangrum AJ, Gomez RA, Norwood VF. Effects of AT1A receptor deletion on blood pressure and sodium excretion during altered dietary salt intake. Am J Physiol Renal Physiol 283: F447-F453, 2002.
26. Manning RD Jr, Meng S, Tian N. Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 179: 243-250, 2003. (Pubitemid 37464109)
27. McGuire JJ, Van Vliet BN, Halfyard SJ. Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR2) knockout mice. BMC Physiol 8: 20, 2008.
28. Oliverio MI, Best CF, Smithies O, Coffman TM. Regulation of sodium balance and blood pressure by the AT1A receptor for angiotensin II. Hypertension 35: 550-554, 2000. (Pubitemid 30108147)
29. Ortlepp JR, Kluge R, Giesen K, Plum L, Radke P, Hanrath P, Joost HG. A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse. Eur J Clin Invest 30: 195-202, 2000. (Pubitemid 30153659)
30. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension. Clinical implications and therapeutic possibilities. Diabetes Care 31: S170-S180, 2008.
31. Rodriguez Iturbe B, Vaziri ND, Herrera Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286: F606-F616, 2004.
32. Rudofsky UH, Dilwith RL, Roths JB, Lawrence DA, Kelley VE, Magro AM. Differences in the occurrence of hypertension among (NZB X NZW) F1, MRL-lpr, and BXSB mice with lupus nephritis. Am J Pathol 116: 107-114, 1984.
33. Sampaio-Maia B, Serrao P, Vieira-Coelho MA, Pestana M. Differences in the renal dopaminerigc system activity between Wistar rats from two suppliers. Acta Physiol Scand 178: 83-89, 2003. (Pubitemid 36577920)
34. Sanada H, Yatabe J, Midorikawa S, Katoh T, Hashimoto S, Watanabe T, Xu J, Luo Y, Wang X, Zeng C, Armando I, Felder RA, Jose PA. Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 47: 1131-1139, 2006. (Pubitemid 44289171)
35. Sakamoto T, Chen C, Lokhandwala MF. Lack of renal dopamine production during acute volume expansion in Dahl salt-sensitive rats. Clin Exp Hypertens 16: 197-206, 1994. (Pubitemid 24135711)
36. Sato M, Soma M, Nakayama T, Kanmatsuse K. Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension 36: 183-186, 2000. (Pubitemid 30626986)
37. Sowers JR, Zemel MB, Zemel P, Back FW, Walsh MF, Zawada ET. Salt sensitivity in blacks. Salt intake and natriuretic substances. Hypertension 12: 485-490, 1988. (Pubitemid 19048353)
38. Staessen JA, Kuznetsova T, Zhang H, Maillard M, Bochud M, Hasenkamp S, Westerkamp J, Richart T, Thijs L, Li X, Brand-Herrmann SM, Burnier M, Brand E. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension 51: 1643-1650, 2008.
39. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics 71: 70-77, 2001. (Pubitemid 32097204)
40. Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension 46: 326-332, 2005.
41. 2 on salt-induced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol 289: R1573-R1579, 2005.
42. Vieira-Coelho MA, Hussain T, Kansra V, Serrao MP, Guimaraes JT, Pestana M, Soares-da-Silva P, Lokhandwala MF. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats. Hypertension 34: 666-672, 1999. (Pubitemid 29496451)
43. Wang X, Villar VA, Armando I, Eisner GM, Felder RA, Jose PA. Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice. Pediatr Nephrol 23: 2131-2146, 2008.
44. Wesseling S, Ishola DA Jr, Joles JA, Bluyssen HA, Koomans HA, Braam B. Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor. Am J Physiol Renal Physiol 288: F1191-F1200, 2005. (Pubitemid 40677089)
45. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289: R913-R935, 2005. (Pubitemid 41397037)
46. + transporters during hypertension or PTH: NHE3 to base of microvilli vs. NaPi2 to endosomes. Am J Physiol Renal Physiol 287: F896-F906, 2004.
47. Yang T, Huang YG, Ye W, Hansen P, Schnermann JB, Briggs JP. Influence of genetic background, and gender on hypertension and renal failure in COX-2-deficient mice. Am J Physiol Renal Physiol 288: F1125-F1132, 2005. (Pubitemid 40677082)
48. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 290: R96-R104, 2006.
49. Yao LP, Li XX, Yu P, Xu J, Asico LD, Jose PA. Dopamine D1 receptor and protein kinase C isoforms in Spontaneously hypertensive rats. Hypertension 32: 1049-1053, 1998. (Pubitemid 29001435)
50. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 19: 233-246, 2004.
51. Zhu J, Huang T, Lombard JH. Effect of high-salt diet on vascular relaxation and oxidative stress in mesenteric resistance arteries. J Vasc Res 44: 382-390, 2007. (Pubitemid 47312659)